Review

Published on 05 Sep 2023

Understanding neuropsychiatric symptoms in Alzheimer’s disease: challenges and advances in diagnosis and treatment

in Neurodegeneration

Andrew Pless
Destany Ware
Shalini Saggu
Hasibur Rehman
John Morgan
Qin Wang

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1263771

9,281 views
20 citations

Original Research

Published on 01 Sep 2023

Common microRNA regulated pathways in Alzheimer’s and Parkinson’s disease

in Neurodegeneration

Betina Awuson-David
Adrian C. Williams
Benjamin Wright
Lisa J. Hill
Valentina Di Pietro

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1228927

3,693 views
4 citations

Original Research

Published on 31 Aug 2023

Nicotine-mediated effects in neuronal and mouse models of synucleinopathy

in Neurodegeneration

Mohamed Bilal Fares
Omar Alijevic
Stephanie Johne
Cassia Overk
Makoto Hashimoto
Athanasios Kondylis
Anthony Adame
Remi Dulize
Dariusz Peric
Catherine Nury

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1239009

4,737 views
5 citations

Original Research

Published on 30 Aug 2023

Unlocking potential: low frequency subthalamic nucleus stimulation enhances executive function in Parkinson’s disease patients with postural instability/gait disturbance

in Neurodegeneration

Guofan Qin
Hutao Xie
Lin Shi
Baotian Zhao
Yifei Gan
Zixiao Yin
Yichen Xu
Xin Zhang
Yaojing Chen
Yin Jiang

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1228711

2,371 views
2 citations

Review

Published on 30 Aug 2023

COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy

in Neurodegeneration

Francisco Gomez
Ashir Mehra
Erik Ensrud
Daniel Diedrich
Krzysztof Laudanski

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1198327

5,985 views
2 citations

Original Research

Published on 25 Aug 2023

Parkinson’s disease model in zebrafish using intraperitoneal MPTP injection

in Neurodegeneration

Noor Azzizah Omar
Jaya Kumar
Seong Lin Teoh

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1236049

3,894 views
13 citations

Editorial

Published on 24 Aug 2023

Editorial: Drosophila as a model to study neurodegenerative diseases

in Neurodegeneration

Francesco Liguori
Udai Bhan Pandey
Filomena Anna Digilio

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1275253

2,478 views
5 citations

Mini Review

Published on 24 Aug 2023

Selective dopaminergic vulnerability in Parkinson’s disease: new insights into the role of DAT

in Neurodegeneration

Maged M. Harraz

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1219441

2,811 views
2 citations

Original Research

Published on 24 Aug 2023

Possible role of locus coeruleus neuronal loss in age-related memory and attention deficits

in Neurodegeneration

Alessandra Gargano
Bolanle Fatimat Olabiyi
Michela Palmisano
Andreas Zimmer
Andras Bilkei-Gorzo

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1264253

2,583 views
5 citations

Opinion

Published on 24 Aug 2023

Do APOE4 and long COVID-19 increase the risk for neurodegenerative diseases in adverse environments and poverty?

in Neurodegeneration

Gabriella C. V. Ciurleo
José Wagner Leonel Tavares-Júnior
Carlos Meton A. G. Vieira
Pedro Braga-Neto
Reinaldo B. Oriá

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1229073

1,938 views
2 citations

Review

Published on 23 Aug 2023

Publicly available ex vivo transcriptomics datasets to explore CNS physiology and neurodegeneration: state of the art and perspectives

in Neurodegeneration

Sandra Abdullatef
Cinthia Farina

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1211079

2,849 views
2 citations

Mini Review

Published on 15 Aug 2023

Neuroprotection from protein misfolding in cerebral hypoperfusion concurrent with metabolic syndrome. A translational perspective

in Neurodegeneration

Sofía Bordet
Juan Pablo Luaces
Maria Ines Herrera
Liliana Mirta Gonzalez
Tamara Kobiec
Santiago Perez-Lloret
Matilde Otero-Losada
Francisco Capani

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1215041

1,798 views

Editorial

Published on 15 Aug 2023

Editorial: Neurological comorbidity in metabolic syndrome

in Neurodegeneration

Matilde Otero-Losada
Anna Marseglia
Eduardo Blanco Calvo
Francisco Capani

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1263570

1,079 views

Review

Published on 15 Aug 2023

The impact of Alzheimer’s disease risk factors on the pupillary light response

in Neurodegeneration

Sierra Sparks
Joana Pinto
Genevieve Hayes
Manuel Spitschan
Daniel P. Bulte

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1248640

3,634 views
1 citation

Original Research

Published on 14 Aug 2023

Minor hallucinations in Parkinson’s disease with probable rapid eye movement sleep behavior disorder

in Neurodegeneration

Yinyin Jiang
Jun Zhu
Yang Zhao
Dongfeng Li
Yaning Chen
Yaxi Wang
Xu Jiang
Bo Shen
Yang Pan
Jun Yan

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1205439

1,733 views
1 citation

Original Research

Published on 10 Aug 2023

BRCA1 heterozygosity promotes DNA damage-induced senescence in a sex-specific manner following repeated mild traumatic brain injury

in Neurodegeneration

Emily Leung
Daria Taskina
Nicole Schwab
Lili-Naz Hazrati

Frontiers in Neuroscience

doi 10.3389/fnins.2023.1225226

1,694 views

Navigation group

Articles

Understanding neuropsychiatric symptoms in Alzheimer’s disease: challenges and advances in diagnosis and treatment

Common microRNA regulated pathways in Alzheimer’s and Parkinson’s disease

Nicotine-mediated effects in neuronal and mouse models of synucleinopathy

Unlocking potential: low frequency subthalamic nucleus stimulation enhances executive function in Parkinson’s disease patients with postural instability/gait disturbance

COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy

Parkinson’s disease model in zebrafish using intraperitoneal MPTP injection

Editorial: Drosophila as a model to study neurodegenerative diseases

Selective dopaminergic vulnerability in Parkinson’s disease: new insights into the role of DAT

Possible role of locus coeruleus neuronal loss in age-related memory and attention deficits

Do APOE4 and long COVID-19 increase the risk for neurodegenerative diseases in adverse environments and poverty?

Publicly available ex vivo transcriptomics datasets to explore CNS physiology and neurodegeneration: state of the art and perspectives

Neuroprotection from protein misfolding in cerebral hypoperfusion concurrent with metabolic syndrome. A translational perspective

Editorial: Neurological comorbidity in metabolic syndrome

The impact of Alzheimer’s disease risk factors on the pupillary light response

Minor hallucinations in Parkinson’s disease with probable rapid eye movement sleep behavior disorder

BRCA1 heterozygosity promotes DNA damage-induced senescence in a sex-specific manner following repeated mild traumatic brain injury